Q0180 Dolasetron mesylate oral
Also known as: Anzemet, dolasetron, 5-HT3 antagonist
Dolasetron mesylate oral formulation, a 5-HT3 receptor antagonist antiemetic used for prevention and treatment of nausea and vomiting.
In Plain Language
anti-nausea pill; anti-vomiting medication
Clinical Context
Used for chemotherapy-induced nausea/vomiting, postoperative nausea, and radiation-induced emesis. Oral formulation suitable for outpatient chemotherapy and post-op management.
RVU Information
CPT Q0180 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Q-codes are temporary HCPCS codes used when no permanent code exists. Coverage and reimbursement vary by payer and region. Document the clinical indication and medical necessity. These codes may be replaced by permanent codes in future HCPCS updates.
Specialties
Frequently Asked Questions
What is CPT code Q0180?
CPT Q0180 (Dolasetron mesylate oral) is a Q Codes code. Dolasetron mesylate oral formulation, a 5-HT3 receptor antagonist antiemetic used for prevention and treatment of nausea and vomiting.
Is Q0180 covered by insurance?
Q0180 is a temporary HCPCS code. Coverage varies by payer and may change when permanent codes are assigned. Used for chemotherapy-induced nausea/vomiting, postoperative nausea, and radiation-induced emesis. Oral formulation suitable for outpatient chemotherapy and post-op management.
When is CPT Q0180 used?
Used for chemotherapy-induced nausea/vomiting, postoperative nausea, and radiation-induced emesis. Oral formulation suitable for outpatient chemotherapy and post-op management.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.